Exelixis Inc. Common Stock vs Opendoor Technologies Inc — how do they compare? Exelixis Inc. Common Stock trades at $58.72 (market cap $14.62B), while Opendoor Technologies Inc trades at $2.32 (market cap $2.22B). The key difference: Exelixis Inc. Common Stock is far larger — about 6.6× Opendoor Technologies Inc's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Opendoor Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 0 Days and Opendoor Technologies Inc for 33 Days on average.
| EXEL | OPEN | |
|---|---|---|
Market Cap | $14.62B | $2.22B |
Volume | 2,684,957 | 28,705,892 |
Sector | Health | Real Estate |
52-Week High | $59.13 | $9.37 |
52-Week Low | $34.54 | $2.27 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $13.95B | $3.29B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Opendoor Technologies (OPEN) trades at $2.27, showing no change in the latest session. The stock faces significant fundamental challenges with a net income margin of -46.74% and negative ROE of -196.89%, though it maintains a reasonable P/S ratio of 0.62. Recent earnings show mixed results with one beat and two misses in the last three quarters. Technical indicators signal bearish momentum with moving averages and oscillators in sell territory, while analyst sentiment remains cautious with 65% hold ratings despite a $4.92 consensus price target representing 117% upside potential.
The outlook remains challenging as the company navigates persistent losses and housing market volatility. While the mortgage expansion initiative and share repurchase program offer potential catalysts, execution risks and macroeconomic headwinds pose significant threats. The substantial gap between current price and analyst targets suggests potential upside if operational improvements materialize, but investors face substantial risk given the company's negative profitability and high debt levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Opendoor Technologies Inc is a digital platform for residential real estate. This platform enables customers to buy and sell houses online. It generates revenue through home sales, along with other revenue from real estate services.
Read more on OPEN →